These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 34713300)

  • 41. miR‑379 inhibits cell proliferation and epithelial‑mesenchymal transition by targeting CHUK through the NF‑κB pathway in non‑small cell lung cancer.
    Liu B; Wang Z; Cheng S; Du L; Yin Y; Yang Z; Zhou J
    Mol Med Rep; 2019 Aug; 20(2):1418-1428. PubMed ID: 31173238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of TGM2 in T‑cell lymphoblastic lymphoma via regulation of IL‑6/JAK/STAT3 signalling.
    Wang Y; Zheng N; Sun T; Zhao H; Chen Y; Liu C
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35014680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DYNC1H1 regulates NSCLC cell growth and metastasis by IFN-γ-JAK-STAT signaling and is associated with an aberrant immune response.
    Pan H; Chai W; Liu X; Yu T; Sun L; Yan M
    Exp Cell Res; 2021 Dec; 409(1):112897. PubMed ID: 34717919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. OTX1 silencing suppresses ovarian cancer progression through inhibiting the JAK/STAT signaling.
    Zhang Q; Li X; Ren L; Gu X; Xiao N; Li N
    Tissue Cell; 2023 Jun; 82():102082. PubMed ID: 37027968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HOXC-AS2 mediates the proliferation, apoptosis, and migration of non-small cell lung cancer by combining with HOXC13 gene.
    Liu B; Li J; Li JM; Liu GY; Wang YS
    Cell Cycle; 2021 Jan; 20(2):236-246. PubMed ID: 33427025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer.
    Zhang N; Zeng Y; Du W; Zhu J; Shen D; Liu Z; Huang JA
    Int J Oncol; 2016 Oct; 49(4):1360-8. PubMed ID: 27499357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT.
    Zhang J; Wang J; Wu J; Huang J; Lin Z; Lin X
    Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35703356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.
    Tang H; Lv W; Sun W; Bi Q; Hao Y
    Int J Mol Med; 2019 Mar; 43(3):1203-1216. PubMed ID: 30628663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis.
    Li S; Mei Z; Hu HB; Zhang X
    J Cell Physiol; 2018 Sep; 233(9):6679-6688. PubMed ID: 29215698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis.
    Wu X; Li X; Xu G
    Oncol Rep; 2020 Aug; 44(2):487-498. PubMed ID: 32468043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis.
    An YX; Shang YJ; Xu ZW; Zhang QC; Wang Z; Xuan WX; Zhang XJ
    Biomed Pharmacother; 2019 Aug; 116():109023. PubMed ID: 31150989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3.
    Zhao Z; Lv B; Zhang L; Zhao N; Lv Y
    Mol Med Rep; 2017 Aug; 16(2):2281-2289. PubMed ID: 28656198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
    Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
    Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.
    Tan X; Jiang L; Wu X; Feng W; Lin Q
    Int J Mol Med; 2019 Jul; 44(1):346-356. PubMed ID: 31115501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer.
    Shien K; Papadimitrakopoulou VA; Ruder D; Behrens C; Shen L; Kalhor N; Song J; Lee JJ; Wang J; Tang X; Herbst RS; Toyooka S; Girard L; Minna JD; Kurie JM; Wistuba II; Izzo JG
    Mol Cancer Ther; 2017 Oct; 16(10):2234-2245. PubMed ID: 28729401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA HOTAIRM1 knockdown inhibits cell glycolysis metabolism and tumor progression by miR-498/ABCE1 axis in non-small cell lung cancer.
    Chen D; Li Y; Wang Y; Xu J
    Genes Genomics; 2021 Feb; 43(2):183-194. PubMed ID: 33537917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between Plasma Cellular Retinoic Acid-Binding Protein 2 and Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer Cells.
    Meng JF; Luo MJ; Li HB
    Crit Rev Eukaryot Gene Expr; 2021; 31(3):81-89. PubMed ID: 34369716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.